• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Devicor Medical backer raising $3 billion fund

Devicor Medical backer raising $3 billion fund

August 9, 2010 By MedCity News

MedCity News logo

The private equity firm behind the purchase of Ethicon Endo-Surgery’s breast care unit from Johnson & Johnson is on its way to raising a $3 billion fund.

GTCR Gold Rauner LLC is raising its tenth fund, according to peHUB. The Chicago firm raised $2.75 billion for its ninth fund in 2006 — before the bottom fell out of financial markets.

Chairman Bruce Rauner’s transition to an advisory role (from sourcing deals) becomes official with the new fund, peHUB reported.

GTCR’s latest fund is not doing well. GTCR Fund IX had an internal rate of return of -16 percent, as of Dec. 31, according to data from the Washington State Investment Board, peHUB said. But Fund VII posted a return of 25.3 percent, while Fund VIII stood at 28.7 percent, the Washington State Board said.

Founded in 1980, GTCR says it pioneered the “leader strategy,” that is, finding and partnering with leaders as the first step to building market-leading companies through acquisitions and organic growth.

In late 2008, the Chicago firm partnered with veteran medical device executive Tom Daulton to set up Devicor Medical Products Group LLC in Pleasant Prairie, Wis., to buy “established interventional medical device businesses that make and sell products to clinicians in hospitals, surgery centers or ambulatory clinics.”

And in early July, Devicor Medical made its first acquisition — the breast care division from Johnson & Johnson’s Ethicon Endo-Surgery unit, for undisclosed terms. The Wisconsin holding company is moving to Sharonville, Ohio, where it has moved the breast care division and its 300 employees, which it renamed Mammotome, a division of Devicor Medical Products.

Devicor Medical said in a regulatory filing last week that it raised $151.5 million. Daulton declined to specify his intentions for that investment. But he told the Cincinnati Enquirer that he planned to invest nearly $300 million in Mammotome over the next few years.

Filed Under: Business/Financial News, News Well Tagged With: Devicor Medical Products, Venture Capital/Private Equity

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy